Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances

被引：3
|
作者：
Aguilar, Gerardo [1 ,2 ,3 ]
Ferriols, Rafael [2 ,3 ,4 ]
Martinez-Castro, Sara [1 ]
Ezquer, Carlos [3 ,4 ]
Pastor, Ernesto [1 ]
Carbonell, Jose A. [1 ]
Alos, Manuel [2 ,3 ,4 ]
Navarro, David [2 ,3 ,5 ]
机构：
[1] Hosp Clin Univ Valencia, Anesthesiol & Crit Care Dept, Crit Care Unit, Valencia, Spain
[2] INCLIVA Hlth Res Inst, Ave Menendez & Pelayo 4, Valencia 46010, Spain
[3] Univ Valencia, Sch Med, Ave Blasco Ibanez 15, Valencia 46010, Spain
[4] Hosp Clin Univ Valencia, Dept Pharm, Ave Blasco Ibanez 17, Valencia 46010, Spain
[5] Hosp Clin Univ Valencia, Dept Microbiol, Ave Blasco Ibanez 17, Valencia 46010, Spain
来源：
CRITICAL CARE | 2020年 / 24卷 / 01期
关键词：
D O I：
10.1186/s13054-019-2724-y
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Successful ceftolozane-tazobactam rescue therapy in a child with endocarditis caused by multidrug-resistant Pseudomonas aeruginosa
    Martin-Cazana, Maria
    Grau, Santiago
    Epalza, Cristina
    Branas, Patricia
    Flores, Marta
    Olmedilla, Marta
    Blazquez-Gamero, Daniel
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2019, 55 (08) : 985 - 987
  • [32] In Vitro Activity of Ceftolozane-Tazobactam against Anaerobic Organisms Identified during the ASPECT-cIAI Study
    Armstrong, Eliana S.
    Farrell, David J.
    Palchak, Melissa
    Steenbergen, Judith N.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (01) : 666 - 668
  • [33] Dosage adjustment of fluconazole during continuous renal replacement therapy (CAVH, CVVH, CAVHD, CVVHD)
    Pittrow, L
    Penk, A
    MYCOSES, 1999, 42 (1-2) : 17 - 19
  • [34] DRUG-DOSAGE IN PATIENTS DURING CONTINUOUS RENAL REPLACEMENT THERAPY - PHARMACOKINETIC AND THERAPEUTIC CONSIDERATIONS
    REETZEBONORDEN, P
    BOHLER, J
    KELLER, E
    CLINICAL PHARMACOKINETICS, 1993, 24 (05) : 362 - 379
  • [35] Optimizing continuous renal replacement therapy in the ICU: a team strategy
    Joannes-Boyau, Olivier
    Velly, Lionel
    Ichai, Carole
    CURRENT OPINION IN CRITICAL CARE, 2018, 24 (06) : 476 - 482
  • [36] Alkalemia during continuous renal replacement therapy
    Journois, Didier
    CRITICAL CARE MEDICINE, 2008, 36 (11) : 3119 - 3120
  • [37] Pharmacokinetics during continuous renal replacement therapy
    Keller, E
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 1996, 19 (02): : 113 - 117
  • [38] Physical compatibility of ceftolozane-tazobactam with selected i.v. drugs during simulated Y-site administration
    Thabit, Abrar K.
    Hamada, Yukihiro
    Nicolau, David P.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (01) : E47 - E54
  • [39] To increase or decrease dosage of antimicrobials in septic patients during continuous renal replacement therapy: the eternal doubt
    Wong, Wai-Tat
    Choi, Gordon
    Gomersall, Charles D.
    Lipman, Jeffrey
    CURRENT OPINION IN PHARMACOLOGY, 2015, 24 : 68 - 76
  • [40] A Population Pharmacokinetic Model-Guided Evaluation of Ceftolozane-Tazobactam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration
    Sime, Fekade B.
    Lassig-Smith, Melissa
    Starr, Therese
    Stuart, Janine
    Pandey, Saurabh
    Parker, Suzanne L.
    Wallis, Steven C.
    Lipman, Jeffrey
    Roberts, Jason A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (01)
12345